Balchem (BCPC) AI Stock Analysis

Balchem

(BMV:BCPC)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong profitability and margin expansionImproving gross, operating, and net margins indicate stronger operating efficiency and a favorable earnings profile. If maintained, this profitability gives Balchem more capacity to fund product development, absorb cost pressure, and convert segment growth into durable earnings over the next several quarters.

Negative Factors

Modest recent revenue growthThe recent top-line pace is modest relative to the company's stronger prior step-up, which may constrain operating leverage and limit the speed of earnings expansion. Sustained profitability therefore depends more heavily on mix, pricing, and execution until broader volume growth accelerates.

Balchem Business Overview & Revenue Model

Company Description

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It o...

Balchem Earnings Call Summary

Earnings Call Date:Oct 22, 2026(Q3-2026)|Next Earnings Date:Feb 18, 2027

Earnings Call SentimentPositive

The call was strongly positive, with record consolidated financial results, growth across all three segments, expanding gross margins, strong cash generation, balance-sheet improvement, continued product and science investment, and confidence in ongoing year-over-year growth. The company also cited challenges including higher input costs, elevated inventory, trade-practice circumvention, oil-price pressure, and normal fourth-quarter seasonality, but these were outweighed by the reported achievements and outlook.

Positive Updates

Record Consolidated Quarterly Results

Balchem reported record third-quarter consolidated revenue of $291 million, up 8.6% year over year; record GAAP earnings from operations of $62 million, up 14.4%; record consolidated net income of $47 million, up 16%; GAAP diluted EPS of $1.46, up 17.7%; record adjusted EBITDA of $80 million, up 12.4%; and record adjusted net earnings of $50 million, up 14.5%, or $1.57 per diluted share, up 16.3%.

Negative Updates

Higher Manufacturing Input Costs

Certain higher manufacturing input costs partially offset gross-margin improvement and segment operating results. Management said the company has experienced raw-material inflation throughout the year and that passing costs through to customers dollar for dollar is slightly margin dilutive as a percentage of sales.

Company Guidance

Balchem said it remains confident in its ability to deliver healthy growth over the long term and healthy year over year growth in the fourth quarter, although the fourth quarter is normally sequentially lower than the third quarter based on historic business seasonality; management expects to be finishing the year in that range of 22.5 to 23 for the effective tax rate, versus 22.7% year to date, and said it is contemplating another sports partnership or maybe 2, with 1 expected to be announced before our next earnings call, or in the next month or so.

Balchem Risk Analysis

Balchem disclosed 26 risk factors in its most recent earnings report. Balchem reported the most risks in the "Production" category.

Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Balchem Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

MX:BCPC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IOSP	76Outperform	$2.46B	20.34	9.15%	1.79%	2.87%	534.76%
IFF	66Neutral	$23.73B	85.34	2.05%	1.72%	-11.72%	―
SXT	62Neutral	$5.01B	29.41	13.66%	1.39%	9.54%	21.44%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SCL	61Neutral	$1.58B	366.37	0.36%	2.27%	10.02%	-90.50%
ASH	56Neutral	$3.42B	65.51	2.77%	2.24%	-1.39%	―

* Basic Materials Sector Average

Performance Comparison

MX:BCPC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
ASH	Ashland Global Holdings, Inc.	74.68	27.76	59.17%
IOSP	Innospec	99.89	27.13	37.28%
IFF	International Flavors & Fragrances	93.02	32.29	53.17%
SXT	Sensient	117.63	27.14	29.99%
SCL	Stepan Company	69.61	28.35	68.72%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Balchem AI Stock Analysis